The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wekerle, T.
Right arrow Articles by Sykes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wekerle, T.
Right arrow Articles by Sykes, M.
The Journal of Immunology, 2001, 166: 2311-2316.
Copyright © 2001 by The American Association of Immunologists

Peripheral Deletion After Bone Marrow Transplantation with Costimulatory Blockade Has Features of Both Activation-Induced Cell Death and Passive Cell Death1

Thomas Wekerle2,*, Josef Kurtz*, Mohamed H. Sayegh{dagger}, Hiroshi Ito*, Andrew D. Wells{ddagger}, Steven Bensinger{ddagger}, Juanita Shaffer*, Laurence A. Turka{ddagger} and Megan Sykes3,*

* BMT Section, Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02129; {dagger} Laboratory of Immunogenetics and Transplantation, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA 02115; and {ddagger} Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104

Two major pathways of death of previously activated T cells have been described: activation-induced cell death can be triggered by restimulating activated T cells with high concentrations of Ag, is Fas-dependent, is not influenced by proteins of the Bcl family, and is blocked by cyclosporin A; in contrast, passive cell death is induced by the withdrawal of growth factors and activation stimuli, is Fas-independent, and is blocked by Bcl family proteins. We examined the role of these two forms of cell death in the peripheral deletion of donor-reactive host T cells after allogeneic bone marrow transplantation and costimulatory blockade with anti-CD154 plus CTLA4Ig in two murine models. The substantial decline in donor-reactive CD4 cells seen in wild-type recipients 1 wk after bone marrow transplantation with costimulatory blockade was largely inhibited in Fas-deficient recipients and in Bcl-xL-transgenic recipients. We observed these effects both in a model involving low-dose total body irradiation and a conventional dose of bone marrow, and in a radiation-free regimen using high-dose bone marrow transplantation. Furthermore, cyclosporin A did not completely block the deletion of donor-reactive CD4+ T cells in recipients of bone marrow transplantation with costimulatory blockade. Thus, the deletion of donor-reactive T cells occurring early after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death. Furthermore, these in vivo data demonstrate for the first time the significance of in vitro results indicating that proteins of the Bcl family can prevent Fas-mediated apoptosis under certain circumstances.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Manicassamy, D. Yin, Z. Zhang, L. L. Molinero, M.-L. Alegre, and Z. Sun
A Critical Role for Protein Kinase C-{theta}-Mediated T Cell Survival in Cardiac Allograft Rejection
J. Immunol., July 1, 2008; 181(1): 513 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Orbach, J. Rachmilewitz, M. Parnas, J.-H. Huang, M. L. Tykocinski, and M. Dranitzki-Elhalel
CTLA-4 {middle dot} FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals
J. Immunol., December 1, 2007; 179(11): 7287 - 7294.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. Najafian, M. J. Albin, and K. A. Newell
How Can We Measure Immunologic Tolerance in Humans?
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2652 - 2663.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Kurtz, J. Shaffer, A. Lie, N. Anosova, G. Benichou, and M. Sykes
Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells
Blood, June 1, 2004; 103(11): 4336 - 4343.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Sandalova, C.-H. Wei, M. G. Masucci, and V. Levitsky
Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering
PNAS, March 2, 2004; 101(9): 3011 - 3016.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Xu, P. M. Chilton, Y. Huang, C. L. Schanie, and S. T. Ildstad
Production of Donor T Cells Is Critical for Induction of Donor-Specific Tolerance and Maintenance of Chimerism
J. Immunol., February 1, 2004; 172(3): 1463 - 1471.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Blaha, S. Bigenzahn, Z. Koporc, M. Schmid, F. Langer, E. Selzer, H. Bergmeister, F. Wrba, J. Kurtz, C. Kiss, et al.
The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade
Blood, April 1, 2003; 101(7): 2886 - 2893.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Chiffoleau, G. Beriou, P. Dutartre, C. Usal, J.-P. Soulillou, and M. C. Cuturi
Role for Thymic and Splenic Regulatory CD4+ T Cells Induced by Donor Dendritic Cells in Allograft Tolerance by LF15-0195 Treatment
J. Immunol., May 15, 2002; 168(10): 5058 - 5069.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.